Home › Bleeding › North Carolina
Bleeding clinical trials in North Carolina
8 studies for Bleeding are looking for participants at sites in North Carolina.
Cities in North Carolina
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Moses Cone Hospital Operating Corporation dba Cone Health, Lebauer-Brodie Center for Cardiovascular Research, Greensboro
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07175428Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Hawthorne Health, Moose Pharmacy of Concord, Concord
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07626411Onyx™ Liquid Embolic IDE Clinical Study
- University of North Carolina at Chapel Hill, Chapel Hill
Recruiting
Ages 22 and older · All sexes · Updated Sep 21, 2026 · NCT06742801A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Duke University Hospital, Durham
- East Carolina University, Greenville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Duke University Health System, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
- Atrium Health Carolinas Medical Center, Charlotte
RecruitingPhase 3
1 Month · All sexes · Updated Jun 30, 2026 · NCT06664775Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Duke University, Durham
- East Carolina University, Greenville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT04045665From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.